DIDI - DiDi Global RLX Technology TG Therapeutics among premarket losers' pack
TG Therapeutics (TGTX) -30% as it withdraws Ukoniq from sale, pulls filing with FDA. Nektar Therapeutics (NKTR) -21% after Nektar, Bristol Myers to end development program for bempegaldesleukin/Opdivo combo. DiDi Global (DIDI) -18% on Q4 earnings release and delisting plans. AIM ImmunoTech (AIM) -11%. Clarus Therapeutics Holdings (CRXT) -9%. Indonesia Energy Corporation (INDO) -6%. Ebang International Holdings (EBON) -7%. Veru (VERU) -7%. RLX Technology (RLX) -6%. Imperial Petroleum (IMPP) -5%. Sunshine Biopharma (SBFM) -7%. Lixte Biotechnology Holdings (LIXT) -5%. Phio Pharmaceuticals (PHIO) -5%.
For further details see:
DiDi Global, RLX Technology, TG Therapeutics among premarket losers' pack